Theriva Biologics reports Q1 2026 financial results in routine earnings disclosure

Filed May 5, 2026 · Period ending May 5, 2026 · ~1 min read

Key Changes

• medium

  Company issued press release with Q1 2026 financial results for quarter ended March 31, 2026. Actual financial figures are in the attached press release exhibit, not in the 8-K body itself.

  Item 2.02 verify on EDGAR →